Search Results - Fjaellskog, Marie‐Louise

  • Showing 1 - 6 results of 6
Refine Results
  1. 1
    P542: A PHASE I/II STUDY TO ASSESS SAFETY, TOLERABILITY AND PRELIMINARY EFFICACY OF BEXMARILIMAB IN COMBINATION WITH STANDARD OF CARE IN PATIENTS WITH MYELOID MALIGNANCIES (BEXMAB)

    P542: A PHASE I/II STUDY TO ASSESS SAFETY, TOLERABILITY AND PRELIMINARY EFFICACY OF BEXMARILIMAB IN COMBINATION WITH STANDARD OF CARE IN PATIENTS WITH MYELOID MALIGNANCIES (BEXMAB) by Kontro, Mika, Siitonen, Timo, Rimpilainen, Johanna, Pyorala, Marja, Pawlitzky, Inka, Aakko, Sofia, Fjaellskog, Marie‐Louise, Hollmén, Maija, Daver, Naval

    Published in HemaSphere
    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    349 Early safety and efficacy of a phase 1/2 open-label, multi-center trial of SNS-301 added to pembrolizumab in patients with advanced squamous cell carcinoma of the head and neck (SCCHN)

    349 Early safety and efficacy of a phase 1/2 open-label, multi-center trial of SNS-301 added to pembrolizumab in patients with advanced squamous cell carcinoma of the head and neck... by Algazi, Alain, Smith, William, Panella, Timothy, Shin, Dong, Fjaellskog, Marie-Louise, Celebi, John, Drumheller, Alice, Campbell, Jean, Pierce, Robert, Guarino, Michael

    Request full text
    Article
    Save to List
    Saved in:
  3. 3
    Encouraging Efficacy Observed in Bexmab Study: A Phase 1/2 Study to Assess Safety and Efficacy of Bexmarilimab in Combination with Standard of Care in Myeloid Malignancies

    Encouraging Efficacy Observed in Bexmab Study: A Phase 1/2 Study to Assess Safety and Efficacy of Bexmarilimab in Combination with Standard of Care in Myeloid Malignancies by Kontro, Mika, Stein, Anthony Selwyn, Pyörälä, Marja, Rimpiläinen, Johanna, Siitonen, Timo, Hollmén, Maija, Fjaellskog, Marie-Louise, Pawlitzky, Inka, Zeidan, Amer M., Daver, Naval

    Published in Blood
    Get full text
    Items that cite this one
    Article
    Save to List
    Saved in:
  4. 4
    709 Phase II Study to assess the safety and efficacy of the CLEVER-1 antibody bexmarilimab in combination with PD-1 blockade in patients with advanced solid tumors – BEXCOMBO

    709 Phase II Study to assess the safety and efficacy of the CLEVER-1 antibody bexmarilimab in combination with PD-1 blockade in patients with advanced solid tumors – BEXCOMBO by Bono, Petri, Jalkanen, Juho, Pawlitzky, Inka, Marie-Louise Fjaellskog, Ahlin, Cecilia

    Get full text
    Article
    Save to List
    Saved in:
  5. 5
    Aberrant expression of cyclin E in low-risk node negative breast cancer

    Aberrant expression of cyclin E in low-risk node negative breast cancer by Ahlin, Cecilia, Gruhne, Bettina, Holmqvist, Marit, Zetterberg, Anders, Fjällskog, Marie-Louise

    Published in Acta oncologica
    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  6. 6
    Reliability of cyclin A assessment on tissue microarrays in breast cancer compared to conventional histological slides

    Reliability of cyclin A assessment on tissue microarrays in breast cancer compared to conventional histological slides by Aaltonen, K, Ahlin, C, Amini, R-M, Salonen, L, Fjällskog, M-L, Heikkilä, P, Nevanlinna, H, Blomqvist, C

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:

Search Tools: